163 related articles for article (PubMed ID: 7497288)
1. [Therapeutic strategies in migraine: introduction].
Noya M
Rev Neurol; 1995; 23 Suppl 2():S201. PubMed ID: 7497288
[No Abstract] [Full Text] [Related]
2. [Therapeutic strategies in menstrual migraine].
Targa C; Massons J
Rev Neurol; 1995; 23 Suppl 2():S226-31. PubMed ID: 7497293
[No Abstract] [Full Text] [Related]
3. [Status migrainosus].
Alberca R; Casado JL; Arenas C; Moreno A; Serrano V
Rev Neurol; 1995; 23 Suppl 2():S208-11. PubMed ID: 7497290
[No Abstract] [Full Text] [Related]
4. Triptan therapy in migraine.
Loder E
N Engl J Med; 2010 Jul; 363(1):63-70. PubMed ID: 20592298
[No Abstract] [Full Text] [Related]
5. Headache.
Vijayan N
West J Med; 1995 Nov; 163(5):474-5. PubMed ID: 8533416
[No Abstract] [Full Text] [Related]
6. Comparison of rizatriptan and sumatriptan.
O'Quinn S; Mansbach H; Salonen R
Headache; 1999 Jan; 39(1):59-60. PubMed ID: 18567177
[No Abstract] [Full Text] [Related]
7. [Treatment of the acute migraine attack].
Titus F
Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
[No Abstract] [Full Text] [Related]
8. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan.
Al-Shekhlee A; Reed R
Neurology; 2000 Sep; 55(5):735-6. PubMed ID: 11041768
[No Abstract] [Full Text] [Related]
9. Recent advances in migraine management.
Cady RK; Shealy CN
J Fam Pract; 1993 Jan; 36(1):85-91. PubMed ID: 8380430
[TBL] [Abstract][Full Text] [Related]
10. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan.
Spierings EL
Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753
[No Abstract] [Full Text] [Related]
11. [Treatment and prophylaxis of an acute migraine attack].
Diener HC; Gendolla A
MMW Fortschr Med; 2004 Sep; 146(35-36):41, 43-5. PubMed ID: 15540539
[TBL] [Abstract][Full Text] [Related]
12. [First generic triptan approved].
MMW Fortschr Med; 2006 Apr; 148(16):62-3. PubMed ID: 16688954
[No Abstract] [Full Text] [Related]
13. [Bonus-malus regulations in the framework of the AVWG guideline-suitable migraine therapy are possible].
MMW Fortschr Med; 2007 May; 149 Suppl 2():102-3. PubMed ID: 17724980
[No Abstract] [Full Text] [Related]
14. [Physiopathology of migraine].
Pascual J; Castro ME
Neurologia; 1998 Jan; 13(1):29-32. PubMed ID: 9522580
[No Abstract] [Full Text] [Related]
15. [Physiopathology of the migraine].
Martínez-Lage JM; Martínez-Vila E
Rev Neurol; 1995; 23(122):789-91. PubMed ID: 7497241
[No Abstract] [Full Text] [Related]
16. Treatment options for acute migraine.
Scholz M
RN; 2000 Oct; 63(10):99. PubMed ID: 11062670
[No Abstract] [Full Text] [Related]
17. [The treatment of migraine].
Titus F
Rev Neurol; 1997 Feb; 25(138):295-300. PubMed ID: 9147762
[No Abstract] [Full Text] [Related]
18. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Van Mil JW
Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659
[No Abstract] [Full Text] [Related]
19. [Strong and sustained-acting triptan. Therewith migraine does not return soon].
MMW Fortschr Med; 2003 Aug; 145(31-32):53. PubMed ID: 14524078
[No Abstract] [Full Text] [Related]
20. Sumatriptan nasal spray for migraine: a review of studies in patients aged 17 years and younger.
Hämäläinen M; Jones M; Loftus J; Saiers J
Int J Clin Pract; 2002 Nov; 56(9):704-9. PubMed ID: 12469987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
